Disc Medicine Prices $450 Million Upsized Public Offering

03:23 AM EDT, 10/21/2026 (MT Newswires) -- Disc Medicine (IRON) has priced an upsized public offering of 6 million shares at $75 per share, to raise roughly $450 million in gross proceeds, the company said late Tuesday. Underwriters have been granted a 30-day option to buy up to an additional 900,000 shares of common stock. The biopharmaceutical company plans to use the net proceeds, along with existing cash, cash equivalents, and marketable securities, to finance research and development of its product candidates, support the potential commercialization of its drug candidate bitopertin, among other purposes, it added. The offering is set to close Thursday.